<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.bpsmedicine.com/feeds/latestarticles/journal?quantity=&amp;format=rss&amp;version=">
        <title>BioPsychoSocial Medicine - Latest Articles</title>
        <link>http://www.bpsmedicine.com</link>
        <description>The latest research articles published by BioPsychoSocial Medicine</description>
        <dc:date>2012-05-03T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.bpsmedicine.com/content/6/1/13" />
                                <rdf:li rdf:resource="http://www.bpsmedicine.com/content/6/1/12" />
                                <rdf:li rdf:resource="http://www.bpsmedicine.com/content/6/1/11" />
                                <rdf:li rdf:resource="http://www.bpsmedicine.com/content/6/1/10" />
                                <rdf:li rdf:resource="http://www.bpsmedicine.com/content/6/1/9" />
                                <rdf:li rdf:resource="http://www.bpsmedicine.com/content/6/1/8" />
                                <rdf:li rdf:resource="http://www.bpsmedicine.com/content/6/1/7" />
                                <rdf:li rdf:resource="http://www.bpsmedicine.com/content/6/1/6" />
                                <rdf:li rdf:resource="http://www.bpsmedicine.com/content/6/1/5" />
                                <rdf:li rdf:resource="http://www.bpsmedicine.com/content/6/1/4" />
                            </rdf:Seq>
        </items>
                 <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.bpsmedicine.com/content/6/1/13">
        <title>Role overload, pain and physical dysfunction in early
rheumatoid or undifferentiated inflammatory arthritis
in Canada</title>
        <description>Background:
Inflammatory arthritis impairs participation in societal roles. Role overload arises when thedemands by a given role set exceed the resources; time and energy, to carry out the requiredtasks. The present study examines the association between role overload and disease outcomes inearly inflammatory arthritis (EIA).
Methods:
Patients (n = 104) of 7.61 months mean duration of inflammatory arthritis completed self-reportquestionnaires on sociodemographics, disease characteristics and role overload. Pain wasassessed using the Short Form McGill Pain Questionnaire (MPQ) and physical functioning wasmeasured with the Medical Outcomes Study Short Form 36 (SF-36) physical functioning score.Role overload was measured by the Role Overload Scale. Patients indicated the number of socialroles they occupied from a total of the three typical roles; marital, parental and paid work.
Results:
Participants&apos; mean age was 56 years and 70.2% were female. Role overload was not correlated tothe number of social roles, however, it was positively associated with pain (p = 0.004) andnegatively associated with physical functioning (p = 0.001). On multivariate analysis, roleoverload was negatively associated with physical functioning after controlling for the relevantsociodemographic variables.
Conclusion:
This study identifies a possible reciprocal relationship between role overload and physicalfunctioning in patients with EIA.</description>
        <link>http://www.bpsmedicine.com/content/6/1/13</link>
                <dc:creator>Sally Sabry Mustafa</dc:creator>
                <dc:creator>Karl Julian Looper</dc:creator>
                <dc:creator>Phyllis Zelkowitz</dc:creator>
                <dc:creator>Margaret Purden</dc:creator>
                <dc:creator>Murray Baron</dc:creator>
                <dc:creator>McGill Early Arthritis Research Group</dc:creator>
                <dc:source>BioPsychoSocial Medicine 2012, null:13</dc:source>
        <dc:date>2012-05-03T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1751-0759-6-13</dc:identifier>
                                <prism:require>/content/figures/1751-0759-6-13-toc.gif</prism:require>
                <prism:publicationName>BioPsychoSocial Medicine</prism:publicationName>
        <prism:issn>1751-0759</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>13</prism:startingPage>
        <prism:publicationDate>2012-05-03T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.bpsmedicine.com/content/6/1/12">
        <title>The development of agoraphobia is associated with the symptoms and location of a patient&apos;s first panic attack</title>
        <description>Background:
The place where a patient experiences his/her first panic attack (FPA) may be related to their agoraphobia later in life. However, no investigations have been done into the clinical features according to the place where the FPA was experienced. In particular, there is an absence of detailed research examining patients who experienced their FPA at home. In this study, patients were classified by the location of their FPA and the differences in their clinical features were explored (e.g., symptoms of FPA, frequency of agoraphobia, and severity of FPA).
Methods:
The subjects comprised 830 panic disorder patients who were classified into 5 groups based on the place of their FPA (home, school/office, driving a car, in a public transportation vehicle, outside of home), The clinical features of these patients were investigated. Additionally, for panic disorder patients with agoraphobia at their initial clinic visit, the clinical features of patients who experienced their FPA at home were compared to those who experienced their attack elsewhere.
Results:
In comparison of the FPAs of the 5 groups, significant differences were seen among the 7 descriptors (sex ratio, drinking status, smoking status, severity of the panic attack, depression score, ratio of agoraphobia, and degree of avoidance behavior) and 4 symptoms (sweating, chest pain, feeling dizzy, and fear of dying). The driving and public transportation group patients showed a higher incidence of co-morbid agoraphobia than did the other groups. Additionally, for panic disorder patients with co-morbid agoraphobia, the at-home group had a higher frequency of fear of dying compared to the patients in the outside-of-home group and felt more severe distress elicited by their FPA.
Conclusion:
The results of this study suggest that the clinical features of panic disorder patients vary according to the place of their FPA. The at-home group patients experienced &quot;fear of dying&quot; more frequently and felt more distress during their FPA than did the subjects in the other groups. These results indicate that patients experiencing their FPA at home should be treated with a focus on the fear and distress elicited by the attack.</description>
        <link>http://www.bpsmedicine.com/content/6/1/12</link>
                <dc:creator>Naomi Hara</dc:creator>
                <dc:creator>Yukika Nishimura</dc:creator>
                <dc:creator>Chika Yokoyama</dc:creator>
                <dc:creator>Ken Inoue</dc:creator>
                <dc:creator>Atsushi Nishida</dc:creator>
                <dc:creator>Hisashi Tanii</dc:creator>
                <dc:creator>Motohiro Okada</dc:creator>
                <dc:creator>Hisanobu Kaiya</dc:creator>
                <dc:creator>Yuji Okazaki</dc:creator>
                <dc:source>BioPsychoSocial Medicine 2012, null:12</dc:source>
        <dc:date>2012-04-11T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1751-0759-6-12</dc:identifier>
                                <prism:require>/content/figures/1751-0759-6-12-toc.gif</prism:require>
                <prism:publicationName>BioPsychoSocial Medicine</prism:publicationName>
        <prism:issn>1751-0759</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>12</prism:startingPage>
        <prism:publicationDate>2012-04-11T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.bpsmedicine.com/content/6/1/11">
        <title>Viz Medicatrix Naturae: does nature &quot;minister to the mind&quot;?</title>
        <description>The healing power of nature, vis medicatrix naturae, has traditionally been defined as an internal healing response designed to restore health. Almost a century ago, famed biologist Sir John Arthur Thomson provided an additional interpretation of the word nature within the context of vis medicatrix, defining it instead as the natural, non-built external environment. He maintained that the healing power of nature is also that associated with mindful contact with the animate and inanimate natural portions of the outdoor environment. A century on, excessive screen-based media consumption, so-called screen time, may be a driving force in masking awareness of the potential benefits of nature. With global environmental concerns, rapid urban expansion, and mental health disorders at crisis levels, diminished nature contact may not be without consequence to the health of the individual and the planet itself. In the context of emerging research, we will re-examine Sir J. Arthur Thomson&apos;s contention that the healing power of the nature-based environment - green space, forests and parks in particular - extends into the realm of mental health and vitality.</description>
        <link>http://www.bpsmedicine.com/content/6/1/11</link>
                <dc:creator>Alan Logan</dc:creator>
                <dc:creator>Eva Selhub</dc:creator>
                <dc:source>BioPsychoSocial Medicine 2012, null:11</dc:source>
        <dc:date>2012-04-03T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1751-0759-6-11</dc:identifier>
                                <prism:require>/content/figures/1751-0759-6-11-toc.gif</prism:require>
                <prism:publicationName>BioPsychoSocial Medicine</prism:publicationName>
        <prism:issn>1751-0759</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>11</prism:startingPage>
        <prism:publicationDate>2012-04-03T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.bpsmedicine.com/content/6/1/10">
        <title>Adolescent chronic fatigue syndrome; a follow-up study displays concurrent improvement of circulatory abnormalities and clinical symptoms 

</title>
        <description>Background:
The pathophysiology of chronic fatigue syndrome (CFS) in adolescents is unknown, and the clinical course and prognosis is still questioned. Recent research indicates that abnormalities of autonomic cardiovascular control may play an important role. The aim of this research project was to perform a follow-up study of adolescents with chronic fatigue syndrome, focusing on clinical symptoms and autonomic cardiovascular control.
Methods:
47 adolescents (12-18 years old) with CFS were recruited from the outpatient clinic at the Department of Pediatrics, Oslo University Hospital. In a primary visit and a follow-up visit (3-17 months later), we evaluated: a) a wide range of complaints and symptoms and b) cardiovascular variables at baseline and during a 20&#176; head-up tilt-test (HUT).
Results:
At the second visit, patients reported significant improvement regarding functional impairments, fatigue severity, muscular pain, concentration problems, post-exertional malaise and the problem of non-relieving rest. Also, at the second visit, baseline heart rate (HR), blood pressure, total peripheral resistance index (TPRI) and LF/HF (low-frequency:high-frequency heart rate variability ratio, an index of sinus node sympathovagal balance derived from spectral analyses of heart rate) were significant lower, and the increases in HR, mean blood pressure (MBP), diastolic blood pressure (DBP) and TPRI during tilt were significantly less pronounced as compared to the first visit. There was a significant correlation between changes in autonomic symptom score, fatigue severity score and functional impairment score from the first to the second visit.
Conclusions:
The majority of adolescents with CFS experienced an improvement over time in functional impairment, self-reported fatigue and additional symptoms, and a concurrent improvement of autonomic cardiovascular control. A possible connection between clinical symptoms and abnormal autonomic control in CFS might represent a focus for further research.</description>
        <link>http://www.bpsmedicine.com/content/6/1/10</link>
                <dc:creator>Dag Sulheim</dc:creator>
                <dc:creator>Harald Hurum</dc:creator>
                <dc:creator>Ingrid Helland</dc:creator>
                <dc:creator>Erik Thaulow</dc:creator>
                <dc:creator>Vegard Wyller</dc:creator>
                <dc:source>BioPsychoSocial Medicine 2012, null:10</dc:source>
        <dc:date>2012-03-21T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1751-0759-6-10</dc:identifier>
                                <prism:require>/content/figures/1751-0759-6-10-toc.gif</prism:require>
                <prism:publicationName>BioPsychoSocial Medicine</prism:publicationName>
        <prism:issn>1751-0759</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>10</prism:startingPage>
        <prism:publicationDate>2012-03-21T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.bpsmedicine.com/content/6/1/9">
        <title>Importance and usefulness of evaluating self-esteem in children</title>
        <description>Self-esteem is the &quot;feeling of self-appreciation&quot; and is an indispensable emotion for people to adapt to society and live their lives. For children, in particular, the environment in which they are raised contributes profoundly to the development of their self-esteem, which in turn helps them to adapt better to society. Various psychologists have provided definitions of self-esteem, and examined methods of objectively evaluating self-esteem. Questionnaire-style assessment methods for adult include Rosenberg Self-Esteem Scale and Janis-Field Feeling of Inadequacy Scale, and these for children include Coopersmith Self-Esteem Inventory, Pope&apos;s 5-Scale Test of Self-Esteem for children, and Kid- KINDL&#174;. Other methods include Ziller Social Self-Esteem Scale and Implicit Association Test. The development of children&apos;s self-esteem is heavily influenced by their environment, that is, their homes, neighborhoods, and schools. Children with damaged self-esteem are at risk of developing psychological and social problems, which hinders recovery from low self-esteem. Thus, to recover low self-esteem, it is important for children to accumulate a series of successful experiences to create a positive concept of self. Evaluating children&apos;s self-esteem can be an effective method for understanding their past and present circumstances, and useful to treat for children with psychosomatic disorders.</description>
        <link>http://www.bpsmedicine.com/content/6/1/9</link>
                <dc:creator>Mizuho Hosogi</dc:creator>
                <dc:creator>Ayumi Okada</dc:creator>
                <dc:creator>Chikako Fujii</dc:creator>
                <dc:creator>Keizou Noguchi</dc:creator>
                <dc:creator>Kumi Watanabe</dc:creator>
                <dc:source>BioPsychoSocial Medicine 2012, null:9</dc:source>
        <dc:date>2012-03-20T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1751-0759-6-9</dc:identifier>
                                <prism:require>/content/figures/1751-0759-6-9-toc.gif</prism:require>
                <prism:publicationName>BioPsychoSocial Medicine</prism:publicationName>
        <prism:issn>1751-0759</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>9</prism:startingPage>
        <prism:publicationDate>2012-03-20T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.bpsmedicine.com/content/6/1/8">
        <title>The transition of adult patients with childhood-onset chronic diseases from pediatric to adult healthcare systems: a survey of the perceptions of Japanese pediatricians and child health nurses</title>
        <description>Background:
Advances in medical science have enabled many children with chronic diseases to survive to adulthood. The transition of adult patients with childhood-onset chronic diseases from pediatric to adult healthcare systems has received attention in Europe and the United States. We conducted a questionnaire survey among 41 pediatricians at pediatric hospitals and 24 nurses specializing in adolescent care to compare the perception of transition of care from pediatric to adult healthcare services for such patients.FindingsThree-fourths of the pediatricians and all of the nurses reported that transition programs were necessary. A higher proportion of the nurses realized the necessity of transition and had already developed such programs. Both pediatricians and nurses reported that a network covering the transition from pediatric to adult healthcare services has not been established to date.
Conclusions:
It has been suggested that spreading the importance of a transition program among pediatricians and developing a pediatric-adult healthcare network would contribute to the biopsychosocial well-being of adult patients with childhood-onset chronic disease.</description>
        <link>http://www.bpsmedicine.com/content/6/1/8</link>
                <dc:creator>Yuko Ishizaki</dc:creator>
                <dc:creator>Mitsue Maru</dc:creator>
                <dc:creator>Hirohiko Higashino</dc:creator>
                <dc:creator>Shoko Katsumoto</dc:creator>
                <dc:creator>Kyoko Egawa</dc:creator>
                <dc:creator>Yoshitoki Yanagimoto</dc:creator>
                <dc:creator>Teruyo Nagahama</dc:creator>
                <dc:source>BioPsychoSocial Medicine 2012, null:8</dc:source>
        <dc:date>2012-03-20T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1751-0759-6-8</dc:identifier>
                                <prism:require>/content/figures/1751-0759-6-8-toc.gif</prism:require>
                <prism:publicationName>BioPsychoSocial Medicine</prism:publicationName>
        <prism:issn>1751-0759</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>8</prism:startingPage>
        <prism:publicationDate>2012-03-20T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.bpsmedicine.com/content/6/1/7">
        <title>Functional near-infrared spectroscopy studies in children</title>
        <description>Psychosomatic and developmental behavioral medicine in pediatrics has been the subject of significant recent attention, with infants, school-age children, and adolescents frequently presenting with psychosomatic, behavioral, and psychiatric symptoms. These may be a consequence of insecurity of attachment, reduced self-confidence, and peer -relationship conflicts during their developmental stages. Developmental cognitive neuroscience has revealed significant associations between specific brain lesions and particular cognitive dysfunctions. Thus, identifying the biological deficits underlying such cognitive dysfunction may provide new insights into therapeutic prospects for the management of those symptoms in children. Recent advances in noninvasive neuroimaging techniques, and especially functional near-infrared spectroscopy (NIRS), have contributed significant findings to the field of developmental cognitive neuroscience in pediatrics. We present here a comprehensive review of functional NIRS studies of children who have developed normally and of children with psychosomatic and behavioral disorders.</description>
        <link>http://www.bpsmedicine.com/content/6/1/7</link>
                <dc:creator>Shinichiro Nagamitsu</dc:creator>
                <dc:creator>Yushiro Yamashita</dc:creator>
                <dc:creator>Hidetaka Tanaka</dc:creator>
                <dc:creator>Toyojiro Matsuishi</dc:creator>
                <dc:source>BioPsychoSocial Medicine 2012, null:7</dc:source>
        <dc:date>2012-03-20T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1751-0759-6-7</dc:identifier>
                                <prism:require>/content/figures/1751-0759-6-7-toc.gif</prism:require>
                <prism:publicationName>BioPsychoSocial Medicine</prism:publicationName>
        <prism:issn>1751-0759</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>7</prism:startingPage>
        <prism:publicationDate>2012-03-20T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.bpsmedicine.com/content/6/1/6">
        <title>Psychosomatic problems and countermeasures in Japanese children and adolescents</title>
        <description>In Japan there are a number of children and adolescents with emotion-related disorders including psychosomatic diseases (orthostatic dysregulation, anorexia nervosa, recurrent pains), behavior problems and school absenteeism. According to our previous report, the Japanese children had significantly higher score of physical symptoms and psychiatric complaints than did the Swedish children, and these were more strongly influenced by school-related stress than by home-related stress. To enforce countermeasures for psychosomatic problems in children, the Japanese Society of Psychosomatic Pediatrics (established in 1982) have started several new projects including multi-center psychosomatic researches and society-based activities. In this article, we present an outline of our study on mental health in Japanese children in comparison with Swedish children. Countermeasures including clinical guidelines for child psychosomatic diseases are reviewed and discussed.</description>
        <link>http://www.bpsmedicine.com/content/6/1/6</link>
                <dc:creator>Hidetaka Tanaka</dc:creator>
                <dc:creator>Shigenori Terashima</dc:creator>
                <dc:creator>Magnus Borres</dc:creator>
                <dc:creator>Olav Thulesius</dc:creator>
                <dc:source>BioPsychoSocial Medicine 2012, null:6</dc:source>
        <dc:date>2012-03-20T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1751-0759-6-6</dc:identifier>
                                <prism:require>/content/figures/1751-0759-6-6-toc.gif</prism:require>
                <prism:publicationName>BioPsychoSocial Medicine</prism:publicationName>
        <prism:issn>1751-0759</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>6</prism:startingPage>
        <prism:publicationDate>2012-03-20T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.bpsmedicine.com/content/6/1/5">
        <title>Behavioral interventions for coronary heart disease patients</title>
        <description>IntroductionThere is a strong clinical need to provide effective stress reduction programs for patients with an acute coronary syndrome. Such programs for men have been implemented and their cardiovascular health benefit documented. For women such programs are scarce.In this report, The feasibility of a cognitive method that was recently demonstrated to prolong lives of women is tested. A setting with gender segregated groups was applied.MethodThe principles of a behavioural health educational program originally designed to attenuate the stress of patients with coronary prone behaviours were used as a basis for the intervention method. For the groups of female patients this method was tailored according to female stressors and for the groups of men according to male stressors. The same core stress reduction program was used for women and men, but the contents of discussions and responses to the pre planned program varied. These were continuously monitored throughout the fifteen sessions. Implementation group: Thirty consecutive patients, eleven women and nineteen men, hospitalized for an acute coronary syndrome were included in this intervention. All expressed their need to learn how to cope with stress in daily life and were highly motivated. Five groups, three groups of men and two groups of women were formed. Psychological assessments were made immediately before and after completion of the program.
Results:
No gender differences in the pre planned programs were found, but discussion styles varied between the women and men, Women were more open and more personal. Family issues were more frequent than job issues, although all women were employed outside their homes. Men talked about concrete and practical things, mostly about their jobs, and not directly about their feelings. Daily stresses of life decreased significantly for both men and women, but more so for women. Depressive thoughts were low at baseline, and there was no change over time. In contrast, anxiety scores were high at baseline and decreased significantly, but more so for women than for men.
Conclusion:
Women are likely to benefit from women&apos;s groups. Men may prefer to have one or two women in the group, but women fare better in gender segregated groups.</description>
        <link>http://www.bpsmedicine.com/content/6/1/5</link>
                <dc:creator>Kristina Orth-Gomer</dc:creator>
                <dc:source>BioPsychoSocial Medicine 2012, null:5</dc:source>
        <dc:date>2012-02-02T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1751-0759-6-5</dc:identifier>
                                <prism:require>/content/figures/1751-0759-6-5-toc.gif</prism:require>
                <prism:publicationName>BioPsychoSocial Medicine</prism:publicationName>
        <prism:issn>1751-0759</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>5</prism:startingPage>
        <prism:publicationDate>2012-02-02T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.bpsmedicine.com/content/6/1/4">
        <title>Somatic comorbidity in anorexia nervosa: First results of a 21-year
follow-up study on female inpatients</title>
        <description>Background:
Anorexia nervosa is a severe psychosomatic disease with somatic complications in the long-term course and a high mortality rate. Somatic comorbidities independent of anorexia nervosa have rarely been studied, but pose a challenge to clinical practitioners. We investigated somatic comorbidities in an inpatient cohort and compared somatically ill anorexic patients and patients without a somatic comorbidity. In order to evaluate the impact of somatic comorbidity for the long-term course of anorexia nervosa, we monitored survival in a long-term follow-up.MethodOne hundred and sixty-nine female inpatients with anorexia nervosa were treated at the Charit&#233; University Medical Centre, Campus Benjamin Franklin, Berlin, between 1979 and 2011. We conducted retrospective analyses using patient&apos;s medical and psychological records. Information on survival and mortality were required through the local registration office and was available for one hundred patients. The mean follow-up interval for this subgroup was m = 20.9 years (sd = 4.7, min = 13.3, max = 31.6, range = 18.3). We conducted survival analysis using cox regression and included somatic comorbidity in a multivariate model.
Results:
N = 41 patients (24.3%) showed a somatic comorbidity, n = 13 patients (7.7%) showed somatic comorbidities related to anorexia nervosa and n = 26 patients (15.4%) showed somatic comorbidities independent of anorexia nervosa, n = 2 patients showed somatic complications related to other psychiatric disorders. Patients with a somatic comorbidity were significantly older (m = 29.5, sd = 10.3 vs m = 25.0, sd = 8.7; p = .006), showed a later anorexia nervosa onset (m = 24.8, sd = 9.9 vs. m = 18.6, sd = 5.1; p &lt; .000) and a longer duration of treatment in our clinic (m = 66.6, sd = 50.3 vs. m = 50.0, sd = 47; p = .05) than inpatients without somatic comorbidity. Out of 100 patients, 9 patients (9%) had died, on average at age of m = 37 years (sd = 9.5). Mortality was more common among inpatients with somatic comorbidity (n = 6, 66.7%) than among inpatients without a somatic disease (n = 3, 33.3%; p = .03). Somatic comorbidity was a significant coefficient in a multivariate survival model (B = 2.32, p = .04).
Conclusion:
Somatic comorbidity seems to be an important factor for anorexia nervosa outcome and should be included in multivariate analyses on the long-term course of anorexia nervosa as an independent variable. Further investigations are needed in order to understand in which way anorexia nervosa and a somatic disease can interact.</description>
        <link>http://www.bpsmedicine.com/content/6/1/4</link>
                <dc:creator>Laurence Erdur</dc:creator>
                <dc:creator>Bettina Kallenbach-Dermutz</dc:creator>
                <dc:creator>Vicky Lehmann</dc:creator>
                <dc:creator>Frank Zimmermann-Viehoff</dc:creator>
                <dc:creator>Werner Kopp</dc:creator>
                <dc:creator>Cora Weber</dc:creator>
                <dc:creator>Hans-Christian Deter</dc:creator>
                <dc:source>BioPsychoSocial Medicine 2012, null:4</dc:source>
        <dc:date>2012-02-02T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1751-0759-6-4</dc:identifier>
                                <prism:require>/content/figures/1751-0759-6-4-toc.gif</prism:require>
                <prism:publicationName>BioPsychoSocial Medicine</prism:publicationName>
        <prism:issn>1751-0759</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>4</prism:startingPage>
        <prism:publicationDate>2012-02-02T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>

